BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer ...Middle East

BERGEN, Norway, Aug. 22, 2023 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, announced today that additional clinical data of bemcentinib in combination with...

Hence then, the article about bergenbio announces clinical data presentations highlighting the activity of its selective axl inhibitor bemcentinib in non small cell lung cancer was published today ( Tuesday 22/08/2023 - 11:57 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer )

Also on site :

• JP Morgan Chase head warns of unexpected interest rate shocks as a result of Iran war
• Thousands of Americans Face New IRS Deadline to Avoid Penalties
• Trump’s Threatening War Crimes. Will Anyone Stop Him?